黄体酮、宫颈环扎术与子宫托预防单胎妊娠早产的有效性:系统综述与网络Meta分析
该系统综述与网络Meta分析纳入36项随机试验(9425名孕妇),比较黄体酮、宫颈环扎术和子宫托预防单胎妊娠早产的效果。黄体酮在多数结局中排名第一或第二,与对照相比降低34周前早产(OR 0.44)、37周前早产(OR 0.58)和新生儿死亡(OR 0.50)。子宫托获益不一致,宫颈环扎术未降低37周前或34周前早产。
要点
- 黄体酮在多数结局中排名第一或第二,降低34周前和37周前早产及新生儿死亡。
- 子宫托获益不一致,宫颈环扎术未降低37周前或34周前早产。
- 在有既往早产史亚组中结果相似,但宫颈短者仅降低34周前早产。
核心结论
- 黄体酮是预防有风险单胎妊娠早产的最佳干预,可降低34周前早产、37周前早产、新生儿死亡及其他后遗症。
研究设计与样本
- 系统综述与网络Meta分析,检索Medline、EMBASE、CINAHL、Cochrane CENTRAL和Web of Science(至2016年4月),无限制,并筛选既往综述的参考文献。
- 纳入36项随机试验,共9425名孕妇,其中25项为低偏倚风险试验。
- 采用贝叶斯随机效应网络Meta分析和配对Meta分析,使用GRADE评级证据质量,SUCRA排序干预措施,并计算需治疗人数(NNT)。
主要发现
- 与对照相比,黄体酮降低34周前早产(OR 0.44;95% CrI 0.22-0.79;NNT 9;低质量证据)。
- 与对照相比,黄体酮降低37周前早产(OR 0.58;95% CrI 0.41-0.79;NNT 9;中等质量证据)。
- 与对照相比,黄体酮降低新生儿死亡(OR 0.50;95% CrI 0.28-0.85;NNT 35;高质量证据)。
- 在有既往早产史亚组中结果相似,但在宫颈短者中仅降低34周前早产。
- 子宫托显示获益不一致,宫颈环扎术未降低37周前或34周前早产。
关键数值与推荐
- 黄体酮降低34周前早产:OR 0.44;95% CrI 0.22-0.79;NNT 9;低质量证据。
- 黄体酮降低37周前早产:OR 0.58;95% CrI 0.41-0.79;NNT 9;中等质量证据。
- 黄体酮降低新生儿死亡:OR 0.50;95% CrI 0.28-0.85;NNT 35;高质量证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preterm birth (PTB) is the leading cause of infant death, but it is unclear which intervention is best to prevent it. OBJECTIVES: To compare progesterone, cerclage and pessary, determine their relative effects and rank them. SEARCH STRATEGY: We searched Medline, EMBASE, CINAHL, Cochrane CENTRAL and Web of Science (to April 2016), without restrictions, and screened references of previous reviews. SELECTION CRITERIA: We included randomised trials of progesterone, cerclage or pessary for preventing PTB in women with singleton pregnancies at risk as defined by each study. DATA COLLECTION AND ANALYSIS: We extracted data by duplicate using a piloted form and performed Bayesian random-effects network meta-analyses and pairwise meta-analyses. We rated evidence quality using GRADE, ranked interventions using SUCRA and calculated numbers needed to treat (NNT). MAIN RESULTS: We included 36 trials (9425 women; 25 low risk of bias trials). Progesterone ranked first or second for most outcomes, reducing PTB < 34 weeks [odds ratio (OR) 0.44; 95% credible interval (CrI) 0.22-0.79; NNT 9; low quality], <37 weeks (OR 0.58; 95% CrI 0.41-0.79; NNT 9; moderate quality), and neonatal death (OR 0.50; 95% CrI 0.28-0.85; NNT 35; high quality), compared with control, in women overall at risk. We found similar results in the subgroup with previous PTB, but only a reduction of PTB < 34 weeks in women with a short cervix. Pessary showed inconsistent benefit and cerclage did not reduce PTB < 37 or <34 weeks. CONCLUSIONS: Progesterone was the best intervention for preventing PTB in singleton pregnancies at risk, reducing PTB < 34 weeks, <37 weeks, neonatal demise and other sequelae. TWEETABLE ABSTRACT: Progesterone was better than cerclage and pessary to prevent preterm birth, neonatal death and more in network meta-analysis.
引用
- Jarde A, Lutsiv O, Park CK, et al. Effectiveness of progesterone, cerclage and pessary for preventing preterm birth in singleton pregnancies: a systematic review and network meta-analysis. BJOG. 2017. PMID: 28276151. doi:10.1111/1471-0528.14624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。